Targets for immunotherapy of liver cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2017.09.007
Abstract: Drug development in hepatocellular carcinoma (HCC) has been characterised by many failures in the past. Despite good rationales and promising phase II data, many phase III trials failed. Immunotherapy represents an alternative treatment approach that… read more here.
Keywords: immunotherapy liver; hcc; targets immunotherapy; based approaches ... See more keywords